CN118373839A - Preparation of a seven-membered bopyin heterocyclic compound and its application in detecting viscosity in organic solutions - Google Patents
Preparation of a seven-membered bopyin heterocyclic compound and its application in detecting viscosity in organic solutions Download PDFInfo
- Publication number
- CN118373839A CN118373839A CN202410507238.7A CN202410507238A CN118373839A CN 118373839 A CN118373839 A CN 118373839A CN 202410507238 A CN202410507238 A CN 202410507238A CN 118373839 A CN118373839 A CN 118373839A
- Authority
- CN
- China
- Prior art keywords
- viscosity
- compound
- membered
- dmf
- bopyin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000002391 heterocyclic compounds Chemical class 0.000 title claims abstract description 13
- 238000002360 preparation method Methods 0.000 title abstract description 3
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims abstract description 24
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 8
- 239000001257 hydrogen Substances 0.000 claims abstract description 8
- 125000001424 substituent group Chemical group 0.000 claims abstract description 5
- 125000004093 cyano group Chemical group *C#N 0.000 claims abstract description 4
- QJQYPZZUKLQGGT-UHFFFAOYSA-N methyl hypobromite Chemical compound COBr QJQYPZZUKLQGGT-UHFFFAOYSA-N 0.000 claims abstract description 4
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims abstract 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 106
- 150000001875 compounds Chemical class 0.000 claims description 21
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 15
- 238000006243 chemical reaction Methods 0.000 claims description 13
- 229940125904 compound 1 Drugs 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 13
- 238000001514 detection method Methods 0.000 claims description 7
- 229940125782 compound 2 Drugs 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 238000003786 synthesis reaction Methods 0.000 claims description 3
- 238000002390 rotary evaporation Methods 0.000 claims description 2
- 238000010898 silica gel chromatography Methods 0.000 claims description 2
- 230000002194 synthesizing effect Effects 0.000 claims description 2
- 238000002525 ultrasonication Methods 0.000 claims description 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- 239000000243 solution Substances 0.000 abstract description 8
- RUKJCCIJLIMGEP-ONEGZZNKSA-N 4-dimethylaminocinnamaldehyde Chemical compound CN(C)C1=CC=C(\C=C\C=O)C=C1 RUKJCCIJLIMGEP-ONEGZZNKSA-N 0.000 abstract description 7
- 239000011259 mixed solution Substances 0.000 abstract description 3
- 238000000746 purification Methods 0.000 abstract description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract 3
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 abstract 2
- USARTISFYYMSBD-UHFFFAOYSA-N N1C=CC=C1.N1C=CC=C1.F[B] Chemical compound N1C=CC=C1.N1C=CC=C1.F[B] USARTISFYYMSBD-UHFFFAOYSA-N 0.000 abstract 1
- 238000000862 absorption spectrum Methods 0.000 abstract 1
- 238000000295 emission spectrum Methods 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
- 238000001308 synthesis method Methods 0.000 abstract 1
- 238000002189 fluorescence spectrum Methods 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 239000010413 mother solution Substances 0.000 description 8
- MCGROFKAAXXTBN-VIZOYTHASA-N 3,5-dihydroxy-N-[(E)-(4-hydroxy-3-nitrophenyl)methylideneamino]benzamide Chemical compound C1=CC(=C(C=C1/C=N/NC(=O)C2=CC(=CC(=C2)O)O)[N+](=O)[O-])O MCGROFKAAXXTBN-VIZOYTHASA-N 0.000 description 5
- 238000004440 column chromatography Methods 0.000 description 5
- 239000000376 reactant Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000012085 test solution Substances 0.000 description 4
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 101001121408 Homo sapiens L-amino-acid oxidase Proteins 0.000 description 1
- 101000827703 Homo sapiens Polyphosphoinositide phosphatase Proteins 0.000 description 1
- 102100026388 L-amino-acid oxidase Human genes 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102100023591 Polyphosphoinositide phosphatase Human genes 0.000 description 1
- 101100012902 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) FIG2 gene Proteins 0.000 description 1
- 101100233916 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) KAR5 gene Proteins 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- -1 fluoroborane dipyrrole derivative Chemical class 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011897 real-time detection Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/022—Boron compounds without C-boron linkages
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N21/643—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" non-biological material
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1007—Non-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1044—Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
- C09K2211/1055—Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms with other heteroatoms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6439—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Optics & Photonics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Molecular Biology (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
本发明公开了一种七元bopyin杂环化合物的制备及在检测有机溶液中的粘度中的应用,所述杂环化合物的结构如下式:。其中,取代基R1为选自氢、甲氧基、溴、氰基中的任意一种。该染料以七元氟硼二吡咯的对位取代衍生物和对二甲氨基肉桂醛为原料,经哌啶、醋酸、三氯氧磷催化、缩合获得,合成方法简单,分离提纯方便,产率较高。不同取代基的引入,使分子的吸收和发射光谱红移,它的结构可用于监测混合溶液中粘度的变化情况。
The present invention discloses the preparation of a seven-membered bopyin heterocyclic compound and its application in detecting the viscosity of an organic solution. The structure of the heterocyclic compound is as follows: . Wherein, the substituent R1 is any one selected from hydrogen, methoxy, bromine, and cyano. The dye is obtained by using a para-substituted derivative of a seven-membered fluoroboron dipyrrole and p-dimethylaminocinnamaldehyde as raw materials, and is catalyzed and condensed by piperidine, acetic acid, and phosphorus oxychloride. The synthesis method is simple, the separation and purification are convenient, and the yield is high. The introduction of different substituents causes the absorption and emission spectra of the molecule to red shift, and its structure can be used to monitor the change of viscosity in a mixed solution.
Description
技术领域Technical Field
本发明涉及一种七元bopyin杂环化合物,更具体的,涉及一种七元bopyin杂环化合物及其粘度应用。The invention relates to a seven-membered bopyin heterocyclic compound, and more specifically to a seven-membered bopyin heterocyclic compound and viscosity application thereof.
背景技术Background technique
黏度作为微环境的关键参数,在生物体内起着重要作用。然而,高黏度值常与心血管疾病、糖尿病和肿瘤等重大疾病相关,因此,黏度的精确检测对于更好地了解相关疾病的病理具有重要意义。As a key parameter of the microenvironment, viscosity plays an important role in organisms. However, high viscosity values are often associated with major diseases such as cardiovascular disease, diabetes, and tumors. Therefore, accurate viscosity detection is of great significance for a better understanding of the pathology of related diseases.
目前被开发和利用的检测粘度的方法和仪器有毛细管粘度计,落球粘度计,旋转粘度计等。其中毛细管粘度计原理简单、但工作效率低而且检测误差较大。旋转式粘度计测量快速方便准确性高,但是这种方法所需的硬件设备多,结构复杂,价格高昂,也就限制了实际中的应用。总之,以上几种方法不适用于小样品或局部粘度的实时检测,但是应用荧光探针的方法就能够有效地避免这些缺陷,因其较高的空间分辨率和时间分辨率,可以进行组织或细胞内成像。因此,开发新型、高效的黏度检测手段用于相关疾病的诊断和病理筛查具有重大价值。The methods and instruments for detecting viscosity that have been developed and used so far include capillary viscometer, falling ball viscometer, rotational viscometer, etc. Among them, the capillary viscometer has a simple principle, but low working efficiency and large detection error. The rotational viscometer is fast, convenient and accurate, but this method requires a lot of hardware equipment, complex structure and high price, which limits its practical application. In short, the above methods are not suitable for real-time detection of small samples or local viscosity, but the method of applying fluorescent probes can effectively avoid these defects, because of its high spatial resolution and time resolution, it can perform tissue or cell imaging. Therefore, it is of great value to develop new and efficient viscosity detection methods for the diagnosis and pathological screening of related diseases.
针对上述问题,本发明所述的是一种七元bopyin杂环化合物荧光探针,因其近红外范围长波长发射,该探针可用于混合溶液中的粘度检测、聚合过程中监测粘度变化、细胞或线粒体中的粘度测量等。并且具有易于检测,反应灵敏,检测范围广等优点。In view of the above problems, the present invention discloses a seven-membered bopyin heterocyclic compound fluorescent probe, which can be used for viscosity detection in mixed solutions, monitoring viscosity changes during polymerization, and viscosity measurement in cells or mitochondria, etc., due to its long-wavelength emission in the near-infrared range. It has the advantages of easy detection, sensitive reaction, and wide detection range.
发明内容Summary of the invention
本发明的主要目的在于提供一种七元bopyin杂环化合物及其粘度应用。本发明的技术方案如下:The main purpose of the present invention is to provide a seven-membered bopyin heterocyclic compound and its viscosity application. The technical solution of the present invention is as follows:
一种七元bopyin杂环化合物及其粘度应用,所述化合物的化学结构式为:A seven-membered bopyin heterocyclic compound and viscosity application thereof, wherein the chemical structural formula of the compound is:
; ;
取代基R为选自氢、甲氧基、溴、氰基中的任意一种。所述的化合物化学结构式为:The substituent R is any one selected from hydrogen, methoxy, bromine, and cyano. The chemical structural formula of the compound is:
中的任意一种。Any one of .
合成所述的七元bopyin杂环化合物的合成方法,所述方法包括以下合成路径:A method for synthesizing the seven-membered bopyin heterocyclic compound, the method comprising the following synthesis path:
; ;
所述方法包括以下步骤:The method comprises the following steps:
(1)在室温下向反应瓶中加入化合物1、化合物2、甲苯,超声溶解,再加入哌啶,加热后得到反应液;(1) Add compound 1, compound 2, and toluene to a reaction bottle at room temperature, dissolve them by ultrasonication, then add piperidine, and heat to obtain a reaction solution;
(2)将步骤(1)中的反应液旋蒸,再经硅胶柱层析分离得到产物Y。化合物1为七元氟硼二吡咯衍生物,化合物2为对二甲氨基肉桂醛;化合物1与化合物2的的投料摩尔比为1:1~2。(2) The reaction solution in step (1) is subjected to rotary evaporation, and then separated by silica gel column chromatography to obtain product Y. Compound 1 is a seven-membered fluoroborane dipyrrole derivative, and compound 2 is p-dimethylaminocinnamaldehyde; the molar ratio of compound 1 to compound 2 is 1:1-2.
(3)所述的步骤(1)的投料顺序为化合物1,化合物2,甲苯,哌啶;化合物1与哌啶的投料比为1:0.3~1。(3) The order of feeding in step (1) is compound 1, compound 2, toluene, and piperidine; the feeding ratio of compound 1 to piperidine is 1:0.3~1.
所述的步骤(1)的加热温度为20~100℃,加热时间为2~5小时。The heating temperature of step (1) is 20-100° C. and the heating time is 2-5 hours.
本发明有益效果如下:The beneficial effects of the present invention are as follows:
(1)本发明的化合物对粘度有一定的响应,化合物本身荧光较弱,但随着粘度的增加,荧光逐渐增强,并且对粘度的最大荧光增强为0.2~2.5倍,提高了粘度监测的成像对比。(1) The compounds of the present invention have a certain response to viscosity. The fluorescence of the compounds themselves is weak, but as the viscosity increases, the fluorescence gradually increases, and the maximum fluorescence enhancement to viscosity is 0.2 to 2.5 times, which improves the imaging contrast of viscosity monitoring.
(2)本发明所述的七元bopyin杂环化合物粘度探针的制备方法简单,所合成的粘度探针在DMF与甘油混合溶液中对粘度响应灵敏。(2) The preparation method of the viscosity probe of the seven-membered bopyin heterocyclic compound described in the present invention is simple, and the synthesized viscosity probe is sensitive to viscosity in a mixed solution of DMF and glycerol.
(3)相较于其他粘度探针,本专利所述粘度探针其中一个化合物最大荧光发射可达820nm左右。(3) Compared with other viscosity probes, the maximum fluorescence emission of one of the compounds in the viscosity probe described in this patent can reach about 820nm.
(4)本发明的合成步骤更简便,反应温度更温和,操作难度小,反应时间快速,最多不超过5h,产率相对较高,后处理纯化简便。(4) The synthesis steps of the present invention are simpler, the reaction temperature is milder, the operation difficulty is small, the reaction time is fast, not exceeding 5 hours at most, the yield is relatively high, and the post-processing and purification are simple.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
图1是实施例1得到的化合物 Y-1的氢谱图。FIG1 is a hydrogen spectrum of compound Y-1 obtained in Example 1.
图2是实施例3得到的化合物 Y-2的氢谱图。FIG2 is a hydrogen spectrum of compound Y-2 obtained in Example 3.
图3是实施例4得到的化合物 Y-3的氢谱图。FIG3 is a hydrogen spectrum of compound Y-3 obtained in Example 4.
图4是实施例5得到的化合物 Y-4的氢谱图。FIG4 is a hydrogen spectrum of compound Y-4 obtained in Example 5.
图5是实施例1得到的化合物 Y-1在不同比例DMF-甘油混合物中的荧光光谱的图。Figure 5 is a graph of the fluorescence spectrum of compound Y-1 obtained in Example 1 in DMF-glycerol mixtures of different proportions.
图6是实施例1得到的化合物 Y-1荧光强度logI807nm与logη的线性关系。FIG6 is a linear relationship between the fluorescence intensity logI 807nm and logη of compound Y-1 obtained in Example 1.
图7是实施例2得到的化合物 Y-2在不同比例DMF-甘油混合物中的荧光光谱的图。Figure 7 is a graph of the fluorescence spectrum of compound Y-2 obtained in Example 2 in DMF-glycerol mixtures of different proportions.
图8是实施例2得到的化合物 Y-2荧光强度logI800nm与logη的线性关系。FIG8 is a linear relationship between the fluorescence intensity logI 800nm and logη of compound Y-2 obtained in Example 2.
图9是实施例3得到的化合物 Y-3在不同比例DMF-甘油混合物中的荧光光谱的图。Figure 9 is a graph of the fluorescence spectrum of compound Y-3 obtained in Example 3 in DMF-glycerol mixtures of different proportions.
图10是实施例3得到的化合物 Y-3荧光强度logI815nm与logη的线性关系。FIG. 10 is a linear relationship between the fluorescence intensity logI 815nm and logη of compound Y-3 obtained in Example 3.
图11是实施例4得到的化合物 Y-4在不同比例DMF-甘油混合物中的荧光光谱的图。Figure 11 is a graph of the fluorescence spectrum of compound Y-4 obtained in Example 4 in DMF-glycerol mixtures of different proportions.
图12是实施例4得到的化合物 Y-4荧光强度logI820nm与logη的线性关系。FIG. 12 is a linear relationship between the fluorescence intensity logI 820nm and logη of compound Y-4 obtained in Example 4.
具体实施方式Detailed ways
下面结合实施例来进一步说明本发明,但本发明要求保护的范围并不局限于实施例表述的范围。The present invention is further described below with reference to embodiments, but the scope of protection claimed by the present invention is not limited to the scope described in the embodiments.
实施例1Example 1
称取化合物1七元氟硼二吡咯化合物(298mg,1 mmol),4-二甲氨基肉桂醛(175mg,1mmol),溶于20mL甲苯,再加入哌啶(59μL,0.3mmol)100℃加热搅拌5小时反应完全,将反应物旋蒸,柱层析纯化后得到紫黑色固体Y-1 (218.4mg),产率48%。Compound 1 (298 mg, 1 mmol) and 4-dimethylaminocinnamaldehyde (175 mg, 1 mmol) were weighed and dissolved in 20 mL of toluene. Piperidine (59 μL, 0.3 mmol) was added and heated at 100 °C with stirring for 5 hours until the reaction was complete. The reactant was rotary evaporated and purified by column chromatography to obtain a purple-black solid Y-1 (218.4 mg) with a yield of 48%.
Y1Y1
实施例2Example 2
称取化合物1七元氟硼二吡咯化合物(298mg,1 mmol),4-二甲氨基肉桂醛(175mg,1mmol),溶于20mL甲苯,再加入哌啶(59μL,0.6mmol)100℃加热搅拌5小时反应完全,将反应物旋蒸,柱层析纯化后得到紫黑色固体Y-1 (273.1mg),产率60%,哌啶的量相对于实施例1增加了1倍,产率提高了12%Compound 1 heptafluoroboranedipyrrole (298 mg, 1 mmol) and 4-dimethylaminocinnamaldehyde (175 mg, 1 mmol) were weighed and dissolved in 20 mL of toluene. Piperidine (59 μL, 0.6 mmol) was added and heated at 100 ° C. and stirred for 5 hours until the reaction was complete. The reactants were rotary evaporated and purified by column chromatography to obtain a purple-black solid Y-1 (273.1 mg) with a yield of 60%. The amount of piperidine was increased by 1 times compared with Example 1, and the yield was increased by 12%.
Y-1Y-1
实施例3Example 3
称取化合物1七元氟硼二吡咯化合物(328mg,1mmol),4-二甲氨基肉桂醛(210mg,1.2mmol),哌啶(99μL,1mmol)100℃加热搅拌3小时反应完全,将反应物旋蒸,柱层析纯化后得到紫黑色固体Y-1 (203.7mg),产率42%。Compound 1 heptafluoroboranedipyrrole (328 mg, 1 mmol), 4-dimethylaminocinnamaldehyde (210 mg, 1.2 mmol), and piperidine (99 μL, 1 mmol) were weighed and heated at 100 °C with stirring for 3 hours until the reaction was complete. The reactants were rotary evaporated and purified by column chromatography to obtain a purple-black solid Y-1 (203.7 mg) with a yield of 42%.
Y-2Y-2
实施例4Example 4
称取化合物1七元氟硼二吡咯化合物(377mg,1mmol),4-二甲氨基肉桂醛(210mg,1.2mmol),哌啶(59μL,0.6mmol)100℃加热搅拌3小时反应完全,将反应物旋蒸,柱层析纯化后得到紫黑色固体Y-1 (224.3mg),产率42%。Compound 1 heptafluoroboranedipyrrole (377 mg, 1 mmol), 4-dimethylaminocinnamaldehyde (210 mg, 1.2 mmol), and piperidine (59 μL, 0.6 mmol) were weighed and heated at 100 °C with stirring for 3 hours until the reaction was complete. The reactants were rotary evaporated and purified by column chromatography to obtain a purple-black solid Y-1 (224.3 mg) with a yield of 42%.
Y-3Y-3
实施例5Example 5
称取化合物1七元氟硼二吡咯化合物(323mg,1mmol),4-二甲氨基肉桂醛(210mg,1.2mmol),哌啶(99μL,1mmol)100℃加热搅拌3小时反应完全,将反应物旋蒸,柱层析纯化后得到紫黑色固体Y-1 (190mg),产率40%。Compound 1 (323 mg, 1 mmol), 4-dimethylaminocinnamaldehyde (210 mg, 1.2 mmol), and piperidine (99 μL, 1 mmol) were weighed and heated at 100 °C with stirring for 3 hours until the reaction was complete. The reactants were rotary evaporated and purified by column chromatography to obtain a purple-black solid Y-1 (190 mg) with a yield of 40%.
Y-4Y-4
实施例6-化合物Y-1对粘度的响应Example 6 - Response of Compound Y-1 to Viscosity
称取化合物Y-1(4.55mg,0.01 mmol)取1mL DMF溶解配成0.01mol/L的母液,然后再各取10μL母液分别溶入3ml不同粘度的DMF与甘油的混合物中,配成33.3μmol/L的待测溶液其中(DMF:甘油=7:3=2.1ml:0.9ml,粘度为4.22mPa·s)、(DMF:甘油=6:4=1.8ml:1.2ml,粘度为7.36mPa·s)(DMF:甘油=5:5=1.5ml:1.5ml,粘度为14.2mPa· s)、(DMF:甘油=4:6=1.2ml:1.8ml,粘度为19.9mPa·s)、(DMF:甘油=3:7=0.9ml:2.1ml,粘度为64.6mPa·s)、(DMF:甘油=2:8=0.6ml:2.4ml,粘度为127.5mPa·s)、(DMF:甘油=1:9=0.3ml:2.7ml,粘度为258.7mPa·s)分别检测它们的荧光光谱,得到图5,并拟合荧光强度logI807nm与logη的线性关系,得到图6。Y-1本身的荧光弱,但随着粘度的增加,荧光强度逐渐增强。粘度系数为4.73,并且对粘度的最大荧光增强为1.2倍。Weigh compound Y-1 (4.55 mg, 0.01 mmol) and dissolve it in 1 mL of DMF to prepare a 0.01 mol/L mother solution. Then, 10 μL of the mother solution was dissolved in 3 ml of a mixture of DMF and glycerol with different viscosities to prepare a 33.3 μmol/L test solution, including (DMF: glycerol = 7:3 = 2.1 ml: 0.9 ml, viscosity is 4.22 mPa·s), (DMF: glycerol = 6:4 = 1.8 ml: 1.2 ml, viscosity is 7.36 mPa·s) (DMF: glycerol = 5:5 = 1.5 ml: 1.5 ml, viscosity is 14.2 mPa·s) s), (DMF: glycerol = 4: 6 = 1.2ml: 1.8ml, viscosity is 19.9mPa·s), (DMF: glycerol = 3: 7 = 0.9ml: 2.1ml, viscosity is 64.6mPa·s), (DMF: glycerol = 2: 8 = 0.6ml: 2.4ml, viscosity is 127.5mPa·s), (DMF: glycerol = 1: 9 = 0.3ml: 2.7ml, viscosity is 258.7mPa·s) respectively detect their fluorescence spectra, get Figure 5, and fit the linear relationship between fluorescence intensity logI 807nm and logη, get Figure 6. Y-1 itself has weak fluorescence, but with the increase of viscosity, the fluorescence intensity gradually increases. The viscosity coefficient is 4.73, and the maximum fluorescence enhancement to viscosity is 1.2 times.
实施例7-化合物Y-2对粘度的响应Example 7 - Response of Compound Y-2 to Viscosity
称取化合物Y-2(4.85mg,0.01 mmol)取1mL DMF溶解配成0.01mol/L的母液,然后再各取10μL母液分别溶入3ml不同粘度的DMF与甘油的混合物中,配成33.3μmol/L的待测溶液其中(DMF:甘油=7:3=2.1ml:0.9ml,粘度为4.22mPa·s)、(DMF:甘油=6:4=1.8ml:1.2ml,粘度为7.36mPa·s)(DMF:甘油=5:5=1.5ml:1.5ml,粘度为14.2mPa· s)、(DMF:甘油=4:6=1.2ml:1.8ml,粘度为19.9mPa·s)、(DMF:甘油=3:7=0.9ml:2.1ml,粘度为64.6mPa·s)、(DMF:甘油=2:8=0.6ml:2.4ml,粘度为127.5mPa·s)、(DMF:甘油=1:9=0.3ml:2.7ml,粘度为258.7mPa·s)分别检测它们的荧光光谱,得到图7,并拟合荧光强度logI807nm与logη的线性关系,得到图8。Y-1本身的荧光弱,但随着粘度的增加,荧光强度逐渐增强。粘度系数为3.83,对粘度的最大荧光增强为2.4倍。Weigh compound Y-2 (4.85 mg, 0.01 mmol) and dissolve it in 1 mL of DMF to prepare a 0.01 mol/L mother solution. Then, 10 μL of the mother solution was dissolved in 3 ml of a mixture of DMF and glycerol with different viscosities to prepare a 33.3 μmol/L test solution, including (DMF: glycerol = 7:3 = 2.1 ml: 0.9 ml, viscosity of 4.22 mPa·s), (DMF: glycerol = 6:4 = 1.8 ml: 1.2 ml, viscosity of 7.36 mPa·s) (DMF: glycerol = 5:5 = 1.5 ml: 1.5 ml, viscosity of 14.2 mPa·s). s), (DMF: glycerol = 4: 6 = 1.2ml: 1.8ml, viscosity is 19.9mPa·s), (DMF: glycerol = 3: 7 = 0.9ml: 2.1ml, viscosity is 64.6mPa·s), (DMF: glycerol = 2: 8 = 0.6ml: 2.4ml, viscosity is 127.5mPa·s), (DMF: glycerol = 1: 9 = 0.3ml: 2.7ml, viscosity is 258.7mPa·s) respectively detect their fluorescence spectra, get Figure 7, and fit the linear relationship between fluorescence intensity logI 807nm and logη, get Figure 8. Y-1 itself has weak fluorescence, but with the increase of viscosity, the fluorescence intensity gradually increases. The viscosity coefficient is 3.83, and the maximum fluorescence enhancement for viscosity is 2.4 times.
实施例8-化合物Y-3对粘度的响应Example 8 - Response of Compound Y-3 to Viscosity
称取化合物Y-3(5.33mg,0.01 mmol)取1mL DMF溶解配成0.01mol/L的母液,然后再各取10μL母液分别溶入3ml不同粘度的DMF与甘油的混合物中,配成33.3μmol/L的待测溶液其中(DMF:甘油=7:3=2.1ml:0.9ml,粘度为4.22mPa·s)、(DMF:甘油=6:4=1.8ml:1.2ml,粘度为7.36mPa·s)(DMF:甘油=5:5=1.5ml:1.5ml,粘度为14.2mPa· s)、(DMF:甘油=4:6=1.2ml:1.8ml,粘度为19.9mPa·s)、(DMF:甘油=3:7=0.9ml:2.1ml,粘度为64.6mPa·s)、(DMF:甘油=2:8=0.6ml:2.4ml,粘度为127.5mPa·s)、(DMF:甘油=1:9=0.3ml:2.7ml,粘度为258.7mPa·s)分别检测它们的荧光光谱,得到图9,并拟合荧光强度logI807nm与logη的线性关系,得到图10,粘度系数为4.70,对粘度的最大荧光增强为1.4倍。Weigh compound Y-3 (5.33 mg, 0.01 mmol) and dissolve it in 1 mL of DMF to prepare a 0.01 mol/L mother solution. Then, 10 μL of the mother solution was dissolved in 3 ml of a mixture of DMF and glycerol with different viscosities to prepare a 33.3 μmol/L test solution, including (DMF: glycerol = 7:3 = 2.1 ml: 0.9 ml, viscosity of 4.22 mPa·s), (DMF: glycerol = 6:4 = 1.8 ml: 1.2 ml, viscosity of 7.36 mPa·s) (DMF: glycerol = 5:5 = 1.5 ml: 1.5 ml, viscosity of 14.2 mPa·s). s), (DMF: glycerol = 4: 6 = 1.2 ml: 1.8 ml, viscosity is 19.9 mPa·s), (DMF: glycerol = 3: 7 = 0.9 ml: 2.1 ml, viscosity is 64.6 mPa·s), (DMF: glycerol = 2: 8 = 0.6 ml: 2.4 ml, viscosity is 127.5 mPa·s), (DMF: glycerol = 1: 9 = 0.3 ml: 2.7 ml, viscosity is 258.7 mPa·s) and their fluorescence spectra were detected respectively to obtain Figure 9, and the linear relationship between the fluorescence intensity logI 807nm and logη was fitted to obtain Figure 10. The viscosity coefficient is 4.70, and the maximum fluorescence enhancement for viscosity is 1.4 times.
实施例9-化合物Y-4对粘度的响应Example 9 - Response of Compound Y-4 to Viscosity
称取化合物Y-4(5.05mg,0.01 mmol)取1mL DMF溶解配成0.01mol/L的母液,然后再各取10μL母液分别溶入3ml不同粘度的DMF与甘油的混合物中,配成33.3μmol/L的待测溶液其中(DMF:甘油=7:3=2.1ml:0.9ml,粘度为4.22mPa·s)、(DMF:甘油=6:4=1.8ml:1.2ml,粘度为7.36mPa·s)(DMF:甘油=5:5=1.5ml:1.5ml,粘度为14.2mPa· s)、(DMF:甘油=4:6=1.2ml:1.8ml,粘度为19.9mPa·s)、(DMF:甘油=3:7=0.9ml:2.1ml,粘度为64.6mPa·s)、(DMF:甘油=2:8=0.6ml:2.4ml,粘度为127.5mPa·s)、(DMF:甘油=1:9=0.3ml:2.7ml,粘度为258.7mPa·s)分别检测它们的荧光光谱,得到图11,并拟合荧光强度logI807nm与logη的线性关系,得到图12,粘度系数为4.20,对粘度的最大荧光增强为2.3倍。Weigh compound Y-4 (5.05 mg, 0.01 mmol) and dissolve it in 1 mL DMF to prepare a 0.01 mol/L mother solution. Then take 10 μL of the mother solution and dissolve it in 3 ml of a mixture of DMF and glycerol with different viscosities to prepare a 33.3 μmol/L test solution, including (DMF: glycerol = 7:3 = 2.1 ml: 0.9 ml, viscosity is 4.22 mPa·s), (DMF: glycerol = 6:4 = 1.8 ml: 1.2 ml, viscosity is 7.36 mPa·s) (DMF: glycerol = 5:5 = 1.5 ml: 1.5 ml, viscosity is 14.2 mPa·s) s), (DMF: glycerol = 4: 6 = 1.2 ml: 1.8 ml, viscosity is 19.9 mPa·s), (DMF: glycerol = 3: 7 = 0.9 ml: 2.1 ml, viscosity is 64.6 mPa·s), (DMF: glycerol = 2: 8 = 0.6 ml: 2.4 ml, viscosity is 127.5 mPa·s), (DMF: glycerol = 1: 9 = 0.3 ml: 2.7 ml, viscosity is 258.7 mPa·s) and their fluorescence spectra were detected respectively to obtain Figure 11, and the linear relationship between the fluorescence intensity logI 807nm and logη was fitted to obtain Figure 12. The viscosity coefficient is 4.20, and the maximum fluorescence enhancement for viscosity is 2.3 times.
上述的实施例仅为本发明的优选技术方案,而不应视为对于本发明的限制,本申请中的实施例及实施例中的特征在不冲突的情况下,可以相互任意组合。本发明的保护范围应以权利要求记载的技术方案,包括权利要求记载的技术方案中技术特征的等同替换方案为保护范围。即在此范围内的等同替换改进,也在本发明的保护范围之内。The above-mentioned embodiments are only preferred technical solutions of the present invention and should not be regarded as limitations of the present invention. The embodiments and features in the embodiments of the present application can be arbitrarily combined with each other without conflict. The protection scope of the present invention shall be the technical solutions recorded in the claims, including the equivalent replacement solutions of the technical features in the technical solutions recorded in the claims. That is, equivalent replacement improvements within this scope are also within the protection scope of the present invention.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410507238.7A CN118373839A (en) | 2024-04-25 | 2024-04-25 | Preparation of a seven-membered bopyin heterocyclic compound and its application in detecting viscosity in organic solutions |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410507238.7A CN118373839A (en) | 2024-04-25 | 2024-04-25 | Preparation of a seven-membered bopyin heterocyclic compound and its application in detecting viscosity in organic solutions |
Publications (1)
Publication Number | Publication Date |
---|---|
CN118373839A true CN118373839A (en) | 2024-07-23 |
Family
ID=91903612
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410507238.7A Pending CN118373839A (en) | 2024-04-25 | 2024-04-25 | Preparation of a seven-membered bopyin heterocyclic compound and its application in detecting viscosity in organic solutions |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN118373839A (en) |
-
2024
- 2024-04-25 CN CN202410507238.7A patent/CN118373839A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104357044B (en) | A kind of fluorescent probe and its preparation method and application | |
Wu et al. | Click synthesis of a triphenylamine-based fluorescent methanol probe with a unique D-π-A structure | |
Tan et al. | 4-(N, N-Dimethylamine) benzonitrile (DMABN) derivatives with boronic acid and boronate groups: new fluorescent sensors for saccharides and fluoride ion | |
Han et al. | Unusual intermolecular charge transfer enables supramolecular fluorescent viscosity sensors | |
CN102618060A (en) | Method for preparing asymmetrical cyanine dye and method for detecting bovine serum albumin by asymmetrical cyanine dye | |
Lanoë et al. | Theoretical and Experimental Study on Boron β‐Diketonate Complexes with Intense Two‐Photon‐Induced Fluorescence in Solution and in the Solid State | |
CN112521383A (en) | Benzothiazole derivatives and their use as fluorescent dyes | |
CN109456250B (en) | Thermally Activated Delayed Fluorescence (TADF) Nanoprobes and Their Preparation and Applications in Bioimaging | |
CN113666966B (en) | Synthesis and Application of a Fluorescent Probe for Detecting Trace Water in Dimethyl Sulfoxide | |
CN113105488B (en) | Synthesis method and application of conjugated BOPYAIN fluorescent dye responding to viscosity | |
Tian et al. | A Deep‐Red to Near Infrared (NIR) Fluorescent Probe Based on a Sulfur‐Modified Rhodamine Derivative with Two Spirolactone Rings | |
CN109053741B (en) | A kind of preparation method and application of perylene diimide pH fluorescent probe | |
CN110194951A (en) | Tetraphenyl ethylene derivatives fluorescent probe and preparation method thereof | |
CN118373839A (en) | Preparation of a seven-membered bopyin heterocyclic compound and its application in detecting viscosity in organic solutions | |
Wang et al. | Multi-Stimuli Responsive Luminescent β-Diketones and Difluoroboron Complexes with Heterocyclic Substituents | |
Wang et al. | Development of Rofecoxib‐Based Fluorophores from ACQ to AIE by Positional Regioisomerization | |
Kumar et al. | BODIPY (aryl) iodonium salts in the efficient synthesis of diversely functionalized BODIPYs and selective detection of serum albumin | |
CN107523292B (en) | A kind of zinc ion fluorescent probe, preparation method and method for detecting zinc ion content | |
CN102795995B (en) | A squaraine chemical sensor for Fe3+ detection and its preparation method | |
Hewavitharanage et al. | Efficient energy transfer in phenyl-ethynyl-linked asymmetric BODIPY dimers | |
CN113121541B (en) | Synthesis and application of a fluorescent probe for simultaneously distinguishing between gold ions Au3+ and palladium | |
Kim et al. | Synthesis and properties of novel rhodamine 6G fluorescent dye compound | |
CN112341453A (en) | Fluorescent probe based on coumarin and preparation method and application thereof | |
CN112898963A (en) | Fluorescent probe for detecting viscosity and preparation method and application thereof | |
CN101417989A (en) | Anion receptor based on nitrofuran formyl hydrazone and phenolic hydroxyl and preparation and use of organagel thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |